124 related articles for article (PubMed ID: 6932177)
1. Acute promyelocytic leukemia--clinical management of 15 patients.
Daly PA; Schiffer CA; Wiernik PH
Am J Hematol; 1980; 8(4):347-59. PubMed ID: 6932177
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
Dreyfus B; Varet B; Heilmann-Gouault M; Sultan C; Reyes F; Gluckman E; Basch A; Beaujean F
Nouv Rev Fr Hematol; 1973; 13(6):761-70. PubMed ID: 4280042
[No Abstract] [Full Text] [Related]
3. Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction.
Collins AJ; Bloomfield CD; Peterson BA; McKenna RW; Edson JR
Arch Intern Med; 1978 Nov; 138(11):1677-80. PubMed ID: 281191
[TBL] [Abstract][Full Text] [Related]
4. THP-ADM in the treatment of acute promyelocytic leukemia.
Uzuka Y; Saito Y
Tohoku J Exp Med; 1985 May; 146(1):1-8. PubMed ID: 3861002
[TBL] [Abstract][Full Text] [Related]
5. Intravascular coagulation and fibrinolysis syndrome (ICF) in acute non-promyelocytic leukemia.
Kotschy M; Kotlarek-Haus S; Podolak-Dawidziak M; Nowicka J; Dzik T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):65-73. PubMed ID: 6157626
[TBL] [Abstract][Full Text] [Related]
6. Acute promyelocytic leukemia in 57 previously untreated patients.
Cordonnier C; Vernant JP; Brun B; Heilmann MG; Kuentz M; Bierling P; Farcet JP; Rodet M; Duedari N; Imbert M
Cancer; 1985 Jan; 55(1):18-25. PubMed ID: 3855265
[TBL] [Abstract][Full Text] [Related]
7. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy.
Arlin Z; Kempin S; Mertelsmann R; Gee T; Higgins C; Jhanwar S; Chaganti RS; Clarkson B
Blood; 1984 Jan; 63(1):211-2. PubMed ID: 6580926
[TBL] [Abstract][Full Text] [Related]
8. [Acute promyelocytic leukemia. Review of the literature].
Virgolini L
Minerva Med; 1984 Jul; 75(30-31):1797-802. PubMed ID: 6090991
[TBL] [Abstract][Full Text] [Related]
9. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic heparin therapy in acute promyelocytic leukemia.
Drapkin RL; Gee TS; Dowling MD; Arlin Z; McKenzie S; Kempin S; Clarkson B
Cancer; 1978 Jun; 41(6):2484-90. PubMed ID: 274995
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of heparin in the management of patients with APL.
Hoyle CF; Swirsky DM; Freedman L; Hayhoe FG
Br J Haematol; 1988 Mar; 68(3):283-9. PubMed ID: 3162683
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia: results of therapy and analysis of 13 cases.
Ruggero D; Baccarani M; Guarini A; Gugliotta L; Gobbi M; Ricci P; Zaccaria A; Lauria F; Tomasini I; Fiacchini M; Santucci MA; Tura S
Acta Haematol; 1977; 58(2):108-19. PubMed ID: 409019
[TBL] [Abstract][Full Text] [Related]
17. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?
Goldberg MA; Ginsburg D; Mayer RJ; Stone RM; Maguire M; Rosenthal DS; Antin JH
Blood; 1987 Jan; 69(1):187-91. PubMed ID: 3466655
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia. M.D. Anderson Hospital experience.
Kantarjian HM; Keating MJ; Walters RS; Estey EH; McCredie KB; Smith TL; Dalton WT; Cork A; Trujillo JM; Freireich EJ
Am J Med; 1986 May; 80(5):789-97. PubMed ID: 3458366
[TBL] [Abstract][Full Text] [Related]
19. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia in children.
Chan KW; Steinherz PG; Miller DR
Med Pediatr Oncol; 1981; 9(1):5-15. PubMed ID: 6936607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
